Home
Company directory
Life science ecosystem
A whole range of premises
Living and working
Team
Media

Accueil » Media

Media

Press releases

Download the press releases on SMO Biopôle Clermont-Limagne and its members.

types de communiqués

SMO Biopôle Clermont-Limagne

Companies

Alphanosos
Aptys Pharma
Carbios
Carbogen Amcis
GIMRA
Icare
Jacquet
Limagrain
METabolic EXplorer
Oncosema
Sabi Agri
Valbiotis
Végépolys Valley

13/06/2023 - METabolic EXplorer

METabolic EXplorer publishes its Sustainability 2022 report (IN FRENCH).

22/05/2023 - Valbiotis

Valbiotis announces the large success of the REVERSE-IT international multicentric Phase II/III clinical study on TOTUM•63: proven efficacy on the main risk factor of developing type 2 diabetes.

05/05/2023 - METabolic EXplorer

Q1 2003 Financial Information (IN FRENCH).

18/04/2023 - Limagrain

Limagrain starts its recruitment campaign! 600 seasonal crops are expected for its summer and autumn harvests (IN FRENCH).

14/04/2023 - Valbiotis

Valbiotis announces its Combined Shareholders General Meeting will be held on May 2, 2023.

03/04/2023 - SMO Biopôle Clermont-Limagne

The pharmaceutical site of Riom La Varenne for 10 years within the SMO Biopôle Clermont-Limagne (IN FRENCH).

30/03/2023 - METabolic EXplorer

F22 – 2023 beginnings and Outlook (IN FRENCH).

13/03/2023 - Valbiotis

Valbiotis announces the last visit of the last patient in the Phase II/III REVERSE-IT study on TOTUM•63, in partnership with Nestlé Health Science.

09/02/2023 - METabolic EXplorer

2022 turnover: €226.6 million (IN FRENCH).

07/02/2023 - METabolic EXplorer

Approval of the agreement concluded by METabolic EXplorer with its main partners on 23 December 2022 under the conciliation procedure (IN FRENCH).

03/02/2023 - Carbogen Amcis

Inauguration of the new production unit of CARBOGEN AMCIS SAS at Biopôle Clermont-Limagne (Saint-Beauzire, Puy de Dôme) Friday, February 3, 2023 (IN FRENCH).

30/01/2023 - Valbiotis

Valbiotis announces positive results in the bioavailability and mode of action TOTUM•854 clinical study, against high blood pressure.

27/01/2023 - METabolic EXplorer

Provisional suspension of the liquidity contract (IN FRENCH).

13/01/2023 - METabolic EXplorer

2023 Financial Schedule (IN FRENCH).

12/01/2023 - METabolic EXplorer

Provision of preparatory documents for the Extraordinary General Assembly (IN FRENCH).

10/01/2023 - Valbiotis

Valbiotis announces its roadmap for 2023: a pivotal year in the execution of its clinical, industrial and commercial strategy.

27/12/2022 - METabolic EXplorer

METabolic EXplorer secures financing for deployment of its strategy.

15/12/2022 - Valbiotis

Valbiotis announces the signature of a research partnership in intestinal microbiota with the MEDIS Unit from the Clermont Auvergne University.

09/11/2022 - Icare

e Icare Group commits to the 2022 Octobre Rose operation

08/11/2022 - METabolic EXplorer

Consolidated sales for the third quarter of 2022: €54.8 million (IN FRENCH).

« Previous 1 2 3 4 5 … 8 Next »

SMO Biopôle Clermont-Limagne
Unrestricted-Public-Sector Association
How
to find us
Manage
my cookies
Legal notice

Colonne de pied de page #1

We use cookies to guarantee the best experience on our site, to make statistics, to offer you third party services such as video like Youtube, social networks sharing. By clicking on validate and closing this banner, you accept the deposit of cookies.Accept Refuse More information

You can revoke your consent at any time by using the "Revoke Consent" button.Revoke consent